Efficacy of chlorhexidine rinses after periodontal or implant surgery: a systematic review

Alex Solderer, Manuela Kaufmann, Deborah Hofer, Daniel Wiedemeier, Thomas Attin, Patrick R Schmidlin, Alex Solderer, Manuela Kaufmann, Deborah Hofer, Daniel Wiedemeier, Thomas Attin, Patrick R Schmidlin

Abstract

Background: Biofilm management and infection control are essential after periodontal and implant surgery. In this context, chlorhexidine (CHX) mouth-rinses are frequently recommended post-surgically. Despite its common use and many studies in this field, a systematic evaluation of the benefits after periodontal or implant surgery is-surprisingly-still missing.

Objectives: To evaluate the benefits of chlorhexidine rinsing after periodontal or implant surgery in terms of plaque and inflammation reduction potential. Furthermore, to screen whether the concentration changes or additives in CHX solutions reduce side effects associated with its use.

Materials and methods: A systematic literature search was performed for clinical trials, which compared CHX rinsing after periodontal or implant surgery with rinsing using placebo, non-staining formulations, or solutions with reduced concentrations of the active compound. Four databases (Medline, PubMed, Embase, Cochrane) were searched up to June 2018. Two reviewers independently identified and screened the literature.

Results: From 691 titles identified, only eleven publications met the inclusion criteria and were finally included. Mainly early publications assessed the benefits of CHX over placebo rinsing, whereas more recent publications focused more on the evaluation of new formulations with regard to effectiveness and side effects. The use of CHX after surgery showed in general significant reduction in plaque (means of 29-86% after 1 week) and bleeding (up to 73%) as compared to placebo. No consensus, however, was found regarding the most beneficial CHX formulation avoiding side effects.

Conclusion: Chlorhexidine rinsing helps to reduce biofilm formation and gingival inflammation after surgery. However, no additional reduction of periodontal probing depth over any given placebo or control solution could be found irrespective of whether CHX was used or not. The use of additives such as antidiscoloration systems (ADS) or herbal extracts may reduce side effects while retaining efficacy.

Clinical relevance: Within the limitations of this review, it can be concluded that CHX may represent a valuable chemo-preventive tool immediately after surgery, during the time period in which oral hygiene capacity is compromised. To reduce the side effects of CHX and maintain comparable clinical effects, rinsing with less concentrated formulations (e.g., 0.12%) showed the most promising results so far.

Keywords: Chlorhexidine; Dental implant; Mouthwashes; Periodontitis.

References

    1. J Clin Periodontol. 1975 Aug;2(3):143-52
    1. J Clin Periodontol. 2000 Jan;27(1):9-15
    1. Minerva Stomatol. 2000 May;49(5):221-6
    1. J Clin Periodontol. 2001 Feb;28(2):168-74
    1. Chem Senses. 2001 Feb;26(2):105-16
    1. J Clin Periodontol. 2001 Jun;28(6):558-64
    1. J Clin Periodontol. 2001 Nov;28(11):1037-44
    1. Caries Res. 2002 Mar-Apr;36(2):93-100
    1. J Periodontal Res. 1976 Jun;11(3):135-44
    1. J Periodontal Res. 1976 Jun;11(3):145-52
    1. J Periodontal Res. 1976 Jun;11(3):153-7
    1. J Clin Dent. 1992;3(2):33-8
    1. Int J Dent Hyg. 2005 May;3(2):59-63
    1. Int J Dent Hyg. 2004 Aug;2(3):122-6
    1. J Clin Periodontol. 2006 May;33(5):334-9
    1. J Clin Periodontol. 2006 Nov;33(11):819-28
    1. J Clin Periodontol. 2008 Jul;35(7):614-20
    1. Anaerobe. 2009 Aug;15(4):164-7
    1. Int J Dent Hyg. 2010 Feb;8(1):35-40
    1. J Clin Periodontol. 2010 Nov;37(11):988-97
    1. Swed Dent J. 2012;36(2):91-9
    1. J Periodontol. 1990 Feb;61(2):112-7
    1. J Dent Res. 1975 Jun;54 Spec No B:B57-62
    1. J Investig Clin Dent. 2014 Feb;5(1):15-22
    1. J Investig Clin Dent. 2011 Feb;2(1):29-37
    1. Int J Dent Hyg. 2017 Feb;15(1):65-72
    1. Pharmacognosy Res. 2015 Jul-Sep;7(3):277-81
    1. Clin Prev Dent. 1989 Sep-Oct;11(5):10-4
    1. Clin Oral Investig. 2016 Nov;20(8):2175-2183
    1. J Periodontol. 1989 Oct;60(10):570-6
    1. J Periodontol. 1989 Oct;60(10):577-81
    1. J Periodontol. 1989 Dec;60(12):704-8
    1. Am J Dent. 2016 Apr;29(2):75-80
    1. BMC Oral Health. 2016 Jul 18;17(1):19
    1. J Clin Diagn Res. 2016 May;10(5):ZC81-3
    1. J Clin Periodontol. 1989 Jul;16(6):385-7
    1. J Periodontol. 1989 Sep;60(9):521-5
    1. J Clin Periodontol. 2017 Mar;44 Suppl 18:S116-S134
    1. J Am Dent Assoc. 2017 May;148(5):308-318
    1. Cochrane Database Syst Rev. 2017 Mar 31;3:CD008676
    1. Clin Oral Investig. 2018 Sep;22(7):2581-2591
    1. J Indian Soc Periodontol. 2017 Jul-Aug;21(4):270-275
    1. Northwest Dent. 1985 Nov-Dec;64(6):15-24
    1. J Clin Periodontol. 1988 Aug;15(7):415-24
    1. Am J Dent. 1988 Dec;1(6):259-63
    1. J Clin Periodontol. 1987 Apr;14(4):205-12
    1. J Periodontal Res Suppl. 1973;12:7-10
    1. J Pharm Pharmacol. 1966 Sep;18(9):569-78
    1. Caries Res. 1971;5(1):23
    1. Scand J Dent Res. 1971;79(2):119-25
    1. J Clin Periodontol. 1981 Jun;8(3):213-9
    1. J Periodontol. 1982 May;53(5):315-8
    1. J Dent Res. 1995 Aug;74(8):1459-67
    1. Scand J Dent Res. 1976 Jul;84(4):224-8
    1. J Clin Periodontol. 1993 Feb;20(2):130-8
    1. Control Clin Trials. 1996 Feb;17(1):1-12
    1. Arch Oral Biol. 1996 Mar;41(3):291-8
    1. J Clin Periodontol. 1998 Jan;25(1):15-23
    1. Periodontol 2000. 1997 Oct;15:55-62

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj